Medical Packaging and Labeling Services

The contract encompasses the packaging and labeling of IOHEXOL in polymer bottles, requiring strict adherence to medical and hazard warning label standards as defined by MMS NO. 1, DFARS, and Federal Standard 313. All activities must comply with federal regulations governing the handling and presentation of pharmaceutical products for military use, ensuring accurate labeling for safety, identification, and regulatory compliance. The work is to be performed at Fort Bragg, North Carolina, with a response deadline of July 29, 2026, and is classified as a subcontract under NAICS code 323113, indicating it involves printing and related support activities for specialized medical packaging. The contract is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, underscoring its relevance to defense medical logistics. While no specific set-aside designation is listed, the solicitation demands full compliance with federal and military standards, suggesting a focus on quality, security, and traceability throughout the packaging and labeling process. The polymer bottles must be suitable for medical use, and labels must include all required hazard and medical information, aligning with DoD procurement procedures and supply chain integrity requirements. Participation requires the capability to meet exacting specifications within a tight timeline and to support the defense medical supply chain with reliable, compliant outputs.